Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fuchs

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Cancer|June 14, 2021
Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungsJun Gui, Farima Zahedi, Angelica Ortiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Potent <i>In Vivo</i> Antitumor Efficacy of Novel Recombinant Type I InterferonKang-Jian Zhang, Xiao-Fei Yin, Yuan-Qin Yang, et al.
Nature Communications|November 4, 2022
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translationBartosz Mucha, Shuo Qie, Sagar Bajpai, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Cancer Cell|January 16, 2019
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular VesiclesAngelica Ortiz, Jun Gui, Farima Zahedi, et al.
Science Translational Medicine|September 15, 2021
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S Lightcap, Pengfei Yu, Stephen Grossman, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Cancer|June 14, 2021
Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungsJun Gui, Farima Zahedi, Angelica Ortiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Potent <i>In Vivo</i> Antitumor Efficacy of Novel Recombinant Type I InterferonKang-Jian Zhang, Xiao-Fei Yin, Yuan-Qin Yang, et al.
Nature Communications|November 4, 2022
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translationBartosz Mucha, Shuo Qie, Sagar Bajpai, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Cancer Cell|January 16, 2019
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular VesiclesAngelica Ortiz, Jun Gui, Farima Zahedi, et al.
Science Translational Medicine|September 15, 2021
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S Lightcap, Pengfei Yu, Stephen Grossman, et al.
Pageof 18